Exact Sciences Corporation
EXAS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,029 | -$204 | -$624 | -$596 |
| Dep. & Amort. | $215 | $207 | $198 | $180 |
| Deferred Tax | -$10 | -$1 | -$12 | -$253 |
| Stock-Based Comp. | $215 | $231 | $207 | $253 |
| Change in WC | -$56 | -$0 | -$26 | $111 |
| Other Non-Cash | $876 | -$76 | $34 | $202 |
| Operating Cash Flow | $211 | $156 | -$224 | -$102 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$136 | -$124 | -$214 | -$136 |
| Net Acquisitions | -$45 | -$52 | -$15 | -$518 |
| Inv. Purchases | -$467 | -$156 | -$174 | -$1,164 |
| Inv. Sales/Matur. | $206 | $383 | $453 | $794 |
| Other Inv. Act. | -$0 | -$0 | $24 | -$59 |
| Investing Cash Flow | -$442 | $50 | $74 | -$1,082 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $217 | $138 | $50 | -$24 |
| Stock Issued | $33 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$18 | $22 | $26 | $32 |
| Financing Cash Flow | $232 | $160 | $76 | $8 |
| Forex Effect | -$3 | $1 | $0 | $0 |
| Net Chg. in Cash | -$3 | $367 | -$73 | -$1,176 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $610 | $243 | $316 | $1,492 |
| End Cash | $607 | $610 | $243 | $316 |
| Free Cash Flow | $75 | $32 | -$438 | -$238 |